Prime Therapeutics — The U.S. Food and Drug Administration (FDA) is close to approving its first official biosimilar – a drug similar to white blood cell-booster Neupogen®. Biosimilars are welcome news. And they’ve been a long time coming. Europe approved its first biosimilar drug nearly a decade ago.